Extensive intratumor regional epigenetic heterogeneity in clear cell renal cell carcinoma targets kidney enhancers and is associated with poor outcome
Abstract Background Clear cell renal cell cancer (ccRCC), the 8th leading cause of cancer-related death in the US, is challenging to treat due to high level intratumoral heterogeneity (ITH) and the paucity of druggable driver mutations. CcRCC is unusual for its high frequency of epigenetic regulator...
Main Authors: | Louis Y. El Khoury, Xiaoyu Pan, Ryan A. Hlady, Ryan T. Wagner, Shafiq Shaikh, Liguo Wang, Mitchell R. Humphreys, Erik P. Castle, Melissa L. Stanton, Thai H. Ho, Keith D. Robertson |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-04-01
|
Series: | Clinical Epigenetics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13148-023-01471-3 |
Similar Items
-
Review the progression of ovarian clear cell carcinoma from the perspective of genomics and epigenomics
by: An Tong, et al.
Published: (2023-02-01) -
Clear cell odontogenic carcinoma versus hyalinizing clear cell carcinoma: A diagnostic dilemma
by: Rama Raju Devaraju, et al.
Published: (2014-01-01) -
Distinctive epigenomes characterize glioma stem cells and their response to differentiation cues
by: Dan Zhou, et al.
Published: (2018-03-01) -
In silico DNA methylation analysis identifies potential prognostic biomarkers in type 2 papillary renal cell carcinoma
by: Man Yang, et al.
Published: (2019-09-01) -
Tumor microenvironment-based signatures distinguish intratumoral heterogeneity, prognosis, and immunogenomic features of clear cell renal cell carcinoma
by: Aihetaimujiang Anwaier, et al.
Published: (2023-09-01)